Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Baxter International ( (BAX) ) has provided an update.
Baxter International Inc. announced a strategic decision to sell its Kidney Care business to affiliates of Carlyle Group Inc., classifying it as a discontinued operation starting in Q3 2024. This move, pending regulatory approvals, aims to streamline Baxter’s financial presentation, impacting how past financials are reported. The change is designed to help investors better analyze Baxter’s ongoing operations, aligning with its strategy to focus on core business areas.
See more insights into BAX stock on TipRanks’ Stock Analysis page.
